# OnCo record anastrozole (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/anastrozole/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "anastrozole" ;
  schema:name "Anastrozole"@en ;
  schema:alternateName "ZD1033"@en, "Arimidex" ;
  schema:description "Anastrozole is a daily tablet that stops the body making oestrogen after the menopause. It treats and prevents hormone-receptor-positive breast cancer and is an alternative to tamoxifen after surgery for ductal carcinoma in situ."@en ;
  schema:url <https://onco.cc/drugs/anastrozole/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Anastrozole> ;
  schema:citation <https://en.wikipedia.org/wiki/Anastrozole> ;
  onco:status "approved" ;
  onco:tag "subtype-drugs-wave" ;
  onco:modality "Oral non-steroidal aromatase inhibitor" ;
  onco:approval "US 1995: Advanced breast cancer in postmenopausal women after tamoxifen", "US 2002: Adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer" ;
  onco:related <https://onco.cc/drugs/letrozole/>, <https://onco.cc/drugs/exemestane/>, <https://onco.cc/drugs/tamoxifen/> ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/ductal-carcinoma-in-situ/> ;
  onco:technologies <https://onco.cc/technologies/endocrine-therapy/> ;
  onco:targets <https://onco.cc/targets/aromatase/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> .